Fig. 1: Proposed mechanism of immunotherapy response augmentation.

High tumor aneuploidy is associated with poor survival following immunotherapy alone. However, the available evidence indicates that simultaneous administration of radiation therapy results in concurrent tumor cell killing and influx of immune cells. These synergistic effects lead to more effective tumor elimination and augmentation of systemic disease response and survival.